574 filings
Page 4 of 29
8-K
4nihnk2c
11 May 23
Agile Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:15pm
8-K
w47 4ma6xb6zky7yg
28 Apr 23
Agile Therapeutics Announces Preliminary Expectations for First Quarter 2023
4:40pm
ARS
dscwwqiju11iaqattqi
28 Apr 23
Annual report to shareholders
8:21am
8-K
vkipgzv
26 Apr 23
Other Events
4:59pm
UPLOAD
b0qbgnb03up auhbvg
19 Apr 23
Letter from SEC
12:00am
424B5
kd98 buwxwft3ge4cqxb
11 Apr 23
Prospectus supplement for primary offering
9:02pm
8-K
q0ekv1u zao911fs1ym
10 Apr 23
Agile Therapeutics Announces 1-FOR-50 Reverse Stock Split
5:16pm
8-K
1ojalfli0hza ap5vd
30 Mar 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:35pm
8-K
8mn58 0qrfm62z4ehz
22 Mar 23
Agile Therapeutics Reports Fourth Quarter & Full Year 2022 Financial Results and Provides Corporate Update
4:15pm
8-K
10o ucmwx
14 Mar 23
Departure of Directors or Certain Officers
4:29pm
8-K
p5n3mbgk4anp8b
27 Feb 23
Agile Therapeutics Granted 180-DAY Extension by Nasdaq to Meet the Minimum Bid Price Requirement
8:30am
SC 13G/A
bujqk6x
14 Feb 23
AGILE THERAPEUTICS / PERCEPTIVE ADVISORS ownership change
2:31pm
SC 13G/A
hkrkyh9x
13 Feb 23
AGILE THERAPEUTICS / Lind Global Fund II ownership change
4:33pm
SC 13G/A
mbrknm6mumgrid u9
8 Feb 23
AGILE THERAPEUTICS / INTRACOASTAL CAPITAL ownership change
6:06am
8-A12G
7km 2tjtn5r
26 Jan 23
Registration of securities
5:20pm
8-K
vs2z2p p0ayzs6y1
26 Jan 23
Agile Therapeutics Announces Distribution of Series C Preferred Stock to Its Holders of Common Stock
5:11pm